Clinical Trial Update: Hypofractionated IMRT With Temozolomide for HGG [NA]

View source ↗

Summary

Clinical trial evaluating hypofractionated IMRT with temozolomide for glioma has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Istituto Clinico Humanitas | Conditions: Glioma | NA | Status: COMPLETED | Results posted: 2020-10-12